Actively Recruiting
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Led by Emory University · Updated on 2025-07-15
30
Participants Needed
1
Research Sites
375 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)
CONDITIONS
Official Title
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pathologically confirmed small cell lung cancer, limited or extensive stage
- Patients offered thoracic radiotherapy with intensity-modulated proton therapy delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction
- Age 18 years or older
You will not qualify if you...
- Prior radiation therapy causing significant overlap with planned treatment areas
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Winship Cancer Institute
Atlanta, Georgia, United States, 30322
Actively Recruiting
Research Team
K
Kristin Higgins, MD
CONTACT
A
Allyson Anderson
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here